Centerline Biomedical, Inc. — Form D

Centerline Biomedical, Inc. of Warrensville Heights, OH, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-25. The offering totals $15.0M, of which $10.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Gulam KhanDirectorWarrensville Heights, OH
Arnaud MarieDirectorWarrensville Heights, OH
Todd SchwarzingerDirectorWarrensville Heights, OH
Michael WhitmanDirectorNewtown, PA
Mitch WolfDirectorWarrensville Heights, OH
Indrani EglestonExecutive OfficerWarrensville Heights, OH
Gulam KhanExecutive OfficerWarrensville Heights, OH
Vikash K GoelExecutive OfficerCleveland, OH
Vinod K GoelDirectorCleveland, OH
Vinod K GoelExecutive OfficerCleveland, OH
Akhil SaklechaDirectorCleveland, OH
Phil RackliffeDirectorCleveland, OH
Phil RackliffeExecutive OfficerCleveland, OH
Phil N RackliffeDirectorCleveland, OH
Phil N RackliffeExecutive OfficerCleveland, OH
Vikash N GoelExecutive OfficerCleveland, OH
Jai N GuptaDirectorCleveland, OH
Jai N GuptaExecutive OfficerCleveland, OH
Jim ZalarDirectorCleveland, OH
Jim N ZalarDirectorCleveland, OH
Karen ShanahanDirectorCleveland, OH

Other filings by this issuer (3)

FiledFormOfferingSold
2023-11-03D$34.7M$34.7M
2023-11-03D$12.7M$12.7M
2023-11-03D$13.7M$13.7M

More